Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Unlimited Watchlists, Portfolios, Screeners, and other Barchart tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact Contact Barchart
Market:
Trevena Inc (TRVN)
Trevena Inc (TRVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Alerts
Watch
Help
Go To:
Trevena: Q1 Earnings Snapshot AP - Mon May 15, 6:17AM CDT

Trevena: Q1 Earnings Snapshot

TRVN : 1.1500 (+6.48%)
Aadi Bioscience, Inc. (AADI) Reports Q1 Loss, Tops Revenue Estimates Zacks - Wed May 10, 8:15AM CDT

Aadi Bioscience, Inc. (AADI) delivered earnings and revenue surprises of 1.72% and 8.99%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

AADI : 7.74 (-0.39%)
TRVN : 1.1500 (+6.48%)
Global Alzheimer’s Disease Diagnostics & Therapeutics Market Expected to Reach $9.6 Billion by 2027 FinancialNewsMedia - Tue May 9, 7:45AM CDT

Palm Beach, FL – May 9, 2023 – FinancialNewsMedia.com News Commentary – Alzheimer’s disease (AD) is a progressive and neurodegenerative disorder that attacks the brain’s nerve cells or neurons,...

IMC.AX : 0.079 (+1.28%)
SILO : 2.05 (-1.44%)
LLY : 425.79 (-0.36%)
ACOR : 0.5946 (-8.52%)
TRVN : 1.1500 (+6.48%)
IMRN : 1.9501 (+3.73%)
Global Alzheimer's Disease Diagnostics & Therapeutics Market Expected to Reach $9.6 Billion by 2027 PR Newswire - Tue May 9, 7:45AM CDT

/PRNewswire/ -- Alzheimer's disease (AD) is a progressive and neurodegenerative disorder that attacks the brain's nerve cells or neurons, which results in loss...

SILO : 2.05 (-1.44%)
LLY : 425.79 (-0.36%)
ACOR : 0.5946 (-8.52%)
TRVN : 1.1500 (+6.48%)
IMRN : 1.9501 (+3.73%)
Trevena (NASDAQ: TRVN) Partner Receives Approval for OLINVYK in China Spotlight Growth - Mon May 8, 1:25PM CDT

Trevena, Inc. (NASDAQ: TRVN) is engaged as a biopharmaceutical company, which is focused on the research, development and commercialization of

TRVN : 1.1500 (+6.48%)
Kiniksa Pharmaceuticals, Ltd. (KNSA) Reports Q1 Loss, Tops Revenue Estimates Zacks - Tue May 2, 7:45AM CDT

Kiniksa Pharmaceuticals, Ltd. (KNSA) delivered earnings and revenue surprises of 0% and 5.22%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

KNSA : 14.07 (+2.18%)
TRVN : 1.1500 (+6.48%)
Trevena: Q4 Earnings Snapshot AP - Thu Mar 30, 6:22AM CDT

Trevena: Q4 Earnings Snapshot

TRVN : 1.1500 (+6.48%)
Trevena (TRVN) Initiates Proof-of-Concept for Epilepsy Candidate Zacks - Thu Mar 9, 9:21AM CST

Trevena (TRVN) has initiated proof-of-concept study to evaluate TRV045 as a potential treatment for epilepsy and other CNS disorders.

TRVN : 1.1500 (+6.48%)
CRSP : 64.66 (+1.27%)
KALA : 15.05 (+1.96%)
ALLO : 5.53 (+1.10%)
Trevena (TRVN) Reports Q3 Loss, Misses Revenue Estimates Zacks - Wed Nov 9, 2022

Trevena (TRVN) delivered earnings and revenue surprises of 0% and 203.06%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

TRVN : 1.1500 (+6.48%)
SPRO : 1.7700 (+1.14%)
Trevena: Q3 Earnings Snapshot AP - Wed Nov 9, 2022

Trevena: Q3 Earnings Snapshot

TRVN : 1.1500 (+6.48%)

Barchart Exclusives

Gold Update – An Explosive Rally Gets Delayed Barchart - Sat May 27, 8:44AM CDT
The continuous gold futures contract rose to an ominous price in May 2023, reaching $2,072 per ounce. The rally took gold to a level creating a technical pattern that sticks out like a sore thumb on the long-term chart. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot